Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5T | 3.9T | 3.4T | 3.6T |
Cost of revenue | 2.3T | 3.6T | 3.3T | 3.2T |
Gross profit | 137.8B | 243.5B | 75.4B | 451.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 20.1B | 26.2B | 25.9B | 22.4B |
Other operating expenses | 3.6B | 11.4B | 1.4B | 2.4B |
Operating income | 94.9B | 175.7B | 31.8B | 410.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 33.1B | 42.3B | 25.8B | 21.0B |
Other income expense | — | — | — | — |
Pretax income | 100.3B | 112.7B | 102.0B | 334.9B |
Tax provision | 22.0B | 21.7B | 18.2B | 76.0B |
Net income | 78.4B | 91.0B | 83.8B | 258.9B |
Basic EPS | 5.1 | — | — | — |
Diluted EPS | 5.1 | — | — | — |
Basic average shares | 15.6B | — | — | — |
Diluted average shares | 15.6B | — | — | — |
EBITDA | 137.6B | 127.1B | 147.8B | 341.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 445.0M | 2.5B | 2.6B | -363.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |